Insight Molecular Diagnostics Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Insight Molecular Diagnostics Inc. stock issued during period, value, other for the quarter ending 2026-06-30 was $0.00.
- Insight Molecular Diagnostics Inc. stock issued during period, value, other for the quarter ending 2026-03-31 was $24.64M, a 14.00% decline year-over-year.
- Insight Molecular Diagnostics Inc. stock issued during period, value, other for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Insight Molecular Diagnostics Inc. stock issued during period, value, other for the quarter ending 2025-09-30 was $0.00.
- Insight Molecular Diagnostics Inc. stock issued during period, value, other for fiscal 2025 was $28.66M, a 16.31% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. stock issued during period, value, other for fiscal 2024 was $24.64M, a 83.58% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. stock issued during period, value, other for fiscal 2023 was $13.42M.
- Insight Molecular Diagnostics Inc. stock issued during period, value, other for fiscal 2021 was -$3.06M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $24.64M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $24.64M 10-Q · filed 2026-05-13 | $24.64M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $28.66M 10-K · filed 2026-03-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $38.02M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $38.02M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $28.66M 10-Q · filed 2026-05-13 | $53.29M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $9.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $24.64M 10-K · filed 2026-03-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | |
| 2024-06-30 | $15.27M 10-Q · filed 2025-08-11 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $13.42M 10-K · filed 2025-03-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2023-06-30 | $13.42M 10-Q · filed 2024-08-08 | |
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | -$3.06M 10-K · filed 2023-04-12 |
| 2021-09-30 | -$187.00K 10-Q · filed 2021-11-09 | |
| 2021-03-31 | -$2.88M 10-Q · filed 2022-05-12 | -$2.94M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$58.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | -$27.00K 10-Q · filed 2021-11-09 | -$122.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$31.00K 10-Q · filed 2021-08-11 | -$95.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-17 | -$65.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | -$3.32M 10-K · filed 2021-03-19 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$3.54M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$3.54M derived: sum of 4 quarters · filed 2020-07-29 |
| 2019-03-31 | -$3.25M 10-Q · filed 2020-05-12 | -$3.61M derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | -$290.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$355.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | |
| 2018-06-30 | -$65.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |